PTK2 and neoplasm: In an early study, treatment of an orthotopic mouse model of PDAC with the selective FAK inhibitor PF-562271 led to a significant reduction in tumor growth and also a decrease in infiltration of both macrophages and CAFs into the tumor, suggesting that this may relieve the immunosuppression imparted by these cell types [125].